Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-25 4:43 pm Purchase | 13D | LENZ THERAPEUTICS INC LENZ | Versant Venture Capital VI L.P. | 2,101,199 8.2% | 2,101,199 (New Position) | View |
| 2024-02-08 5:44 pm Unchanged | 13D | ALIGOS THERAPEUTICS INC ALGS | Versant Venture Capital VI L.P. | 1,457,937 1.9% | 0 (Unchanged) | View |
| 2024-02-08 5:41 pm Unchanged | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 11% | 0 (Unchanged) | View |
| 2024-02-08 5:35 pm Unchanged | 13G | CENTURY THERAPEUTICS INC IPSC | Versant Venture Capital VI L.P. | 11,452,014 19.1% | 0 (Unchanged) | View |
| 2023-11-17 4:38 pm Unchanged | 13D | GRAPHITE BIO INC GRPH | Versant Venture Capital VI L.P. | 14,708,398 25.4% | 0 (Unchanged) | View |
| 2023-11-09 5:28 pm Unchanged | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 15.9% | 0 (Unchanged) | View |
| 2023-11-09 5:27 pm Unchanged | 13D | PASSAGE BIO INC PASG | Versant Venture Capital VI L.P. | 4,026,417 7.3% | 0 (Unchanged) | View |
| 2023-11-09 5:26 pm Unchanged | 13D | MONTE ROSA THERAPEUTICS INC CO GLUE | Versant Venture Capital VI L.P. | 6,799,115 13.7% | 0 (Unchanged) | View |
| 2023-11-09 5:24 pm Unchanged | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | Versant Venture Capital VI L.P. | 4,328,883 8.4% | 0 (Unchanged) | View |
| 2023-02-09 4:19 pm Sale | 13G | CENTURY THERAPEUTICS INC IPSC | Versant Venture Capital VI L.P. | 11,452,014 19.4% | -914,800 (-7.40%) | View |
| 2023-01-13 4:09 pm Sale | 13D | OYSTER PT PHARMA INC OYST | Versant Venture Capital VI L.P. | 0 0% | -2,236,888 (Position Closed) | View |
| 2022-05-09 5:26 pm Purchase | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 20.5% | 940,173 (+79.78%) | View |
| 2022-02-10 8:39 pm Purchase | 13G | CENTURY THERAPEUTICS INC IPSC | Versant Venture Capital VI L.P. | 12,366,814 22.6% | 12,366,814 (New Position) | View |
| 2022-02-10 7:41 pm Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 1,178,471 17.1% | 1,178,471 (New Position) | View |
| 2022-01-13 4:34 pm Unchanged | 13D | OYSTER PT PHARMA INC OYST | Versant Venture Capital VI L.P. | 2,236,888 8.5% | 0 (Unchanged) | View |
| 2021-10-27 4:32 pm Unchanged | 13D | OYSTER PT PHARMA INC OYST | Versant Venture Capital VI L.P. | 2,236,888 8.6% | 0 (Unchanged) | View |
| 2021-07-09 4:43 pm Purchase | 13D | GRAPHITE BIO INC GRPH | Versant Venture Capital VI L.P. | 14,708,398 26.3% | 14,708,398 (New Position) | View |
| 2021-07-08 4:31 pm Purchase | 13D | MONTE ROSA THERAPEUTICS INC CO GLUE | Versant Venture Capital VI L.P. | 6,799,115 15.3% | 6,799,115 (New Position) | View |
| 2021-06-21 4:44 pm Sale | 13D | ALIGOS THERAPEUTICS INC ALGS | Versant Venture Capital VI L.P. | 1,457,937 3.8% | -485,979 (-25.00%) | View |
| 2021-05-24 4:27 pm Unchanged | 13D | OYSTER PT PHARMA INC OYST | Versant Venture Capital VI L.P. | 2,236,888 8.6% | 0 (Unchanged) | View |